Stocktoria
MADRIGAL PHARMACEUTICALS, INC. MDGL
MADRIGAL PHARMACEUTICALS, INC. financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $958.4M | $180.1M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | — |
| SG&A expense | $813.8M | $435.1M | $108.1M | $48.1M | — | — | — | — | — | — |
| Operating income | -$300.1M | -$497.9M | -$380.5M | -$293.6M | -$242.5M | -$206.7M | -$95.0M | -$40.7M | -$32.1M | -$25.2M |
| Interest expense | — | — | $12.7M | $4.0M | $0 | $0 | — | — | — | $1.2M |
| Income tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | — | — |
| Net income | -$288.3M | -$465.9M | -$373.6M | -$295.4M | -$241.8M | -$202.2M | -$83.9M | -$32.8M | -$31.2M | -$26.4M |
| EPS (diluted) | $-10.15 | $-17.31 | $-17.33 | $-17.23 | $-14.63 | $-13.09 | — | — | — | — |
| Operating cash flow | -$189.6M | -$455.6M | -$324.2M | -$224.9M | -$183.9M | -$157.6M | -$41.6M | -$25.5M | -$22.3M | -$17.6M |
| Free cash flow | -$190.0M | -$457.0M | -$325.7M | -$225.1M | -$184.1M | -$157.9M | -$41.8M | -$25.5M | -$22.4M | -$17.6M |
| Cash & equivalents | $198.7M | $100.0M | $99.9M | $331.5M | $36.3M | $54.0M | $46.7M | $57.4M | $148.6M | $19.1M |
| Inventory | $74.8M | $34.1M | $0 | — | — | — | — | — | — | — |
| Total assets | $1.3B | $1.0B | $640.5M | $362.6M | $273.3M | $287.0M | $442.1M | $485.4M | $192.3M | $41.2M |
| Total liabilities | $656.9M | $287.9M | $235.2M | $165.2M | $77.2M | $47.0M | $25.5M | $8.4M | $10.1M | $4.8M |
| Shareholders' equity | $602.7M | $754.4M | $405.3M | $197.4M | $196.1M | $240.0M | $416.6M | $477.0M | $182.3M | $36.4M |
Growth · year-over-year
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +432.1% | — | — | — | — | — | — | — | — | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.